Nottingham Prognostic Index Plus: Validation of a clinical decision making tool in breast cancer in an independent series-Reference-Cited by-同舟云学术

Nottingham Prognostic Index Plus: Validation of a clinical decision making tool in breast cancer in an independent series

Published:2016-01 Issue:1 Volume:2 Page:32-40
ISSN:2056-4538
Container-title:The Journal of Pathology: Clinical Research
language:en
Short-container-title:J Path: Clin Res

Author:

Green Andrew R¹,Soria Daniele²³,Stephen Jacqueline⁴,Powe Desmond G⁵,Nolan Christopher C¹,Kunkler Ian⁶,Thomas Jeremy⁷,Kerr Gillian R⁶,Jack Wilma⁷,Cameron David⁶,Piper Tammy⁷,Ball Graham R⁸,Garibaldi Jonathan M²³,Rakha Emad A¹⁵,Bartlett John MS⁶⁹,Ellis Ian O¹⁵

Affiliation:

1. Division of Cancer and Stem Cells; Breast Cancer Pathology Research Group, School of Medicine, University of Nottingham, Nottingham City Hospital; Hucknall Road Nottingham NG5 1PB

2. Intelligent Modelling & Analysis Research Group; School of Computer Science; University of Nottingham, Jubilee Campus; Wollaton Road Nottingham NG8 1BB

3. Advanced Data Analysis Centre, University of Nottingham, University Park; Nottingham NG7 2RD

4. School of Molecular, Genetic and Population Health Sciences; Centre for Population Health Sciences, Medical School, University of Edinburgh; Teviot Place Edinburgh EH8 9AG

5. Cellular Pathology, Nottingham University Hospitals NHS Trust; Hucknall Road Nottingham NG5 1PB

6. The Institute of Genetics and Molecular Medicine; Edinburgh Cancer Research Centre, University of Edinburgh, Western General Hospital; Crewe Road South Edinburgh EH4 2XR

7. Edinburgh Breast Unit, Western General Hospital; Crewe Road South Edinburgh EH4 2XU

8. John van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent University; Nottingham NG11 8NS

9. Transformative Pathology; Ontario Institute for Cancer Research, MaRS Centre; 661 University Avenue, Suite 510 Toronto Canada M5G 0A3

Funder

MRC DPFS

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Reference32 articles.

1. Genomic analyses to select patients for adjuvant chemotherapy: trials and tribulations;Weigelt;Ann Oncol,2012

2. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer;Paik;N Engl J Med,2004

3. A gene-expression signature as a predictor of survival in breast cancer;Vijver;N Engl J Med,2002

4. The Nottingham Prognostic Index in primary breast cancer;Galea;Breast Cancer Res Treat,1992

5. The Nottingham Prognostic Index applied to 9,149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG);Balslev;Breast Cancer Res Treat,1994

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking the Potential of AI in Cancer Therapeutics: Advancements in Treatment Selection, Swift Diagnosis, Risk Assessment, and Prognosis;Current Cancer Therapy Reviews;2024-06-04

2. Identification of Patients with Early HR+ HER2− Breast Cancer at High Risk of Recurrence;Geburtshilfe und Frauenheilkunde;2024-02

3. Multiparametric MRI-based radiomics combined with pathomics features for prediction of the efficacy of neoadjuvant chemotherapy in breast cancer;Heliyon;2024-01

4. Optimizing the average distance between a blue light photosensitizer and a harmonic nanoparticle for effective infrared photodynamic therapy;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2023-12

5. Systematic review highlights high risk of bias of clinical prediction models for blood transfusion in patients undergoing elective surgery;Journal of Clinical Epidemiology;2023-07